Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

Long-acting FSH versus daily FSH for women undergoing assisted reproduction.

Pouwer AW, Farquhar C, Kremer JA.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD009577. doi: 10.1002/14651858.CD009577.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD009577.

PMID:
22696386
2.

Long-acting FSH versus daily FSH for women undergoing assisted reproduction.

Pouwer AW, Farquhar C, Kremer JA.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD009577. doi: 10.1002/14651858.CD009577.pub3. Review.

PMID:
26171903
3.

Luteal phase support for assisted reproduction cycles.

van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD009154. doi: 10.1002/14651858.CD009154.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;7:CD009154.

PMID:
21975790
4.

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.

Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M.

Cochrane Database Syst Rev. 2014 Oct 31;(10):CD008046. doi: 10.1002/14651858.CD008046.pub4. Review.

PMID:
25358904
5.

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.

Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ.

Cochrane Database Syst Rev. 2016 Apr 29;4:CD001750. doi: 10.1002/14651858.CD001750.pub4. Review.

PMID:
27126581
6.

Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.

Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S.

Cochrane Database Syst Rev. 2015 Nov 9;(11):CD006919. doi: 10.1002/14651858.CD006919.pub4. Review.

PMID:
26558801
7.

Natural cycle in vitro fertilisation (IVF) for subfertile couples.

Allersma T, Farquhar C, Cantineau AE.

Cochrane Database Syst Rev. 2013 Aug 30;(8):CD010550. doi: 10.1002/14651858.CD010550.pub2. Review.

PMID:
23990351
8.

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.

Nagels HE, Rishworth JR, Siristatidis CS, Kroon B.

Cochrane Database Syst Rev. 2015 Nov 26;(11):CD009749. doi: 10.1002/14651858.CD009749.pub2. Review.

PMID:
26608695
9.

FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.

Martins WP, Vieira AD, Figueiredo JB, Nastri CO.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD010042. doi: 10.1002/14651858.CD010042.pub2. Review.

PMID:
23543584
10.

Luteal phase support for assisted reproduction cycles.

van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M.

Cochrane Database Syst Rev. 2015 Jul 7;(7):CD009154. doi: 10.1002/14651858.CD009154.pub3. Review.

PMID:
26148507
11.

Assisted reproductive technologies for male subfertility.

Cissen M, Bensdorp A, Cohlen BJ, Repping S, de Bruin JP, van Wely M.

Cochrane Database Syst Rev. 2016 Feb 26;2:CD000360. doi: 10.1002/14651858.CD000360.pub5. Review.

PMID:
26915339
12.

Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles.

Mochtar MH, Van der Veen, Ziech M, van Wely M.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005070. Review.

PMID:
17443569
13.

Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.

Albuquerque LE, Tso LO, Saconato H, Albuquerque MC, Macedo CR.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD002808. doi: 10.1002/14651858.CD002808.pub3. Review.

PMID:
23440788
14.

Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.

Youssef MA, Abou-Setta AM, Lam WS.

Cochrane Database Syst Rev. 2016 Apr 23;4:CD003719. doi: 10.1002/14651858.CD003719.pub4. Review.

PMID:
27106604
15.

Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.

Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M.

Cochrane Database Syst Rev. 2017 May 24;5:CD005070. doi: 10.1002/14651858.CD005070.pub3. [Epub ahead of print] Review.

PMID:
28537052
16.

Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles.

van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, Al-Inany HG.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005354. doi: 10.1002/14651858.CD005354.pub2. Review.

PMID:
21328276
17.

In vitro fertilisation for unexplained subfertility.

Pandian Z, Gibreel A, Bhattacharya S.

Cochrane Database Syst Rev. 2015 Nov 19;(11):CD003357. doi: 10.1002/14651858.CD003357.pub4. Review.

PMID:
26583517
18.

Volume expanders for the prevention of ovarian hyperstimulation syndrome.

Youssef MA, Mourad S.

Cochrane Database Syst Rev. 2016 Aug 31;(8):CD001302. doi: 10.1002/14651858.CD001302.pub3. Review.

PMID:
27577848
19.

Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).

Kwan I, Bhattacharya S, Kang A, Woolner A.

Cochrane Database Syst Rev. 2014 Aug 24;(8):CD005289. doi: 10.1002/14651858.CD005289.pub3. Review.

PMID:
25150465
20.

Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.

Weiss NS, Nahuis M, Bayram N, Mol BW, Van der Veen F, van Wely M.

Cochrane Database Syst Rev. 2015 Sep 9;(9):CD010290. doi: 10.1002/14651858.CD010290.pub2. Review.

PMID:
26350625

Supplemental Content

Support Center